FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma



The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.
Medscape Medical News



Source link : https://www.medscape.com/viewarticle/fda-oks-upfront-nivolumab-chemo-classic-hodgkin-lymphoma-2026a10008lu?src=rss

Author :

Publish date : 2026-03-20 19:09:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version